Home/Filings/4/0001209191-15-058117
4//SEC Filing

AMICUS THERAPEUTICS INC 4

Accession 0001209191-15-058117

$FOLDCIK 0001178879operating

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:27 PM ET

Size

13.9 KB

Accession

0001209191-15-058117

Insider Transaction Report

Form 4
Period: 2015-07-01
Gershkowitz Jayne
VP, Patient Advocacy
Transactions
  • Sale

    Common stock

    2015-07-01$13.97/sh10,649$148,8185,693 total
  • Exercise/Conversion

    Common stock

    2015-07-01$13.97/sh+10,649$148,81816,342 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-07-013,46328,075 total
    Exercise: $2.52From: 2014-06-18Exp: 2023-06-18Common stock (3,463 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-07-014,37426,252 total
    Exercise: $3.53From: 2014-01-28Exp: 2023-01-28Common Stock (4,374 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-07-012,81239,376 total
    Exercise: $2.45From: 2015-01-03Exp: 2024-01-03Common stock (2,812 underlying)
Footnotes (3)
  • [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
  • [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.87 to $14.15. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.87 to $14.15. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

AMICUS THERAPEUTICS INC

CIK 0001178879

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001178879

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:27 PM ET
Size
13.9 KB